We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$14.8B
AUM Growth
+$2.92B
(+25%)
Cap. Flow
+$3.28B
Cap. Flow
% of AUM
22.14%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
1,029
New
443
Increased
269
Reduced
185
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$217M |
| 2 |
Apple
AAPL
|
+$208M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Amazon
AMZN
|
+$136M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$125M |
| 2 |
Gilead Sciences
GILD
|
+$107M |
| 3 |
PR
Permian Resources
PR
|
+$85.4M |
| 4 |
Reddit
RDDT
|
+$84.1M |
| 5 |
Keysight
KEYS
|
+$79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.96% |
| 2 | Technology | 25.64% |
| 3 | Financials | 7.58% |
| 4 | Industrials | 6.88% |
| 5 | Communication Services | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
State Street
STT
$51.4B
| $1.73M | 0.01% |
+17,605
| New | +$1.67M |
|
|
TERN
677
DELISTED
Terns Pharmaceuticals
TERN
| $1.73M | 0.01% |
311,612
+10,388
| +3% | +$70.3K |
|
678
Raymond James Financial
RJF
$34.7B
| $1.71M | 0.01% |
+10,988
| New | +$1.66M |
|
|
FITB
679
Fifth Third Bancorp
FITB
$52.2B
| $1.7M | 0.01% |
+40,269
| New | +$1.81M |
|
680
Tractor Supply
TSCO
$17.5B
| $1.7M | 0.01% |
+32,081
| New | +$1.81M |
|
681
Synchrony
SYF
$25.8B
| $1.7M | 0.01% |
+26,122
| New | +$1.6M |
|
682
Xylem
XYL
$28.5B
| $1.69M | 0.01% |
14,590
-3,767
| -21% | -$476K |
|
683
Dow Inc
DOW
$21.4B
| $1.69M | 0.01% |
+42,043
| New | +$1.96M |
|
684
Celsius Holdings
CELH
$7.45B
| $1.68M | 0.01% |
+63,946
| New | +$1.9M |
|
685
Pliant Therapeutics
PLRX
$65M
| $1.68M | 0.01% |
127,295
+15,635
| +14% | +$213K |
|
686
PPG Industries
PPG
$26.5B
| $1.66M | 0.01% |
+13,933
| New | +$1.74M |
|
687
Kraft Heinz
KHC
$30.5B
| $1.63M | 0.01% |
+53,010
| New | +$1.74M |
|
688
NVR
NVR
$17B
| $1.61M | 0.01% |
197
-995
| -83% | -$9.06M |
|
689
Zentalis Pharmaceuticals
ZNTL
$352M
| $1.61M | 0.01% |
530,582
-524,700
| -50% | -$1.72M |
|
|
SW
690
Smurfit Westrock
SW
$25.4B
| $1.6M | 0.01% |
+29,676
| New | +$1.51M |
|
691
National Vision
EYE
$1.85B
| $1.59M | 0.01% |
152,422
-146,609
| -49% | -$1.6M |
|
692
Monolithic Power Systems
MPWR
$66.1B
| $1.58M | 0.01% |
+2,667
| New | +$1.93M |
|
693
Xenon Pharmaceuticals
XENE
$6.19B
| $1.57M | 0.01% |
+39,938
| New | +$1.65M |
|
694
Carnival Corporation Ltd
CCL
$40.6B
| $1.55M | 0.01% |
+62,381
| New | +$1.46M |
|
695
Norfolk Southern
NSC
$76.8B
| $1.51M | 0.01% |
+6,454
| New | +$1.64M |
|
696
T. Rowe Price
TROW
$24.5B
| $1.51M | 0.01% |
+13,342
| New | +$1.54M |
|
697
Kura Oncology
KURA
$817M
| $1.5M | 0.01% |
172,704
+29,497
| +21% | +$424K |
|
698
DTE Energy
DTE
$29.1B
| $1.5M | 0.01% |
+12,437
| New | +$1.53M |
|
699
Ventas
VTR
$47.5B
| $1.48M | 0.01% |
+25,087
| New | +$1.58M |
|
700
Sysco
SYY
$40.3B
| $1.46M | 0.01% |
19,153
-113,130
| -86% | -$8.66M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Woodline Partners held 1,029 positions worth $14.8B, up 25% from $11.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Woodline Partners deployed $3.28B of net new capital in Q4 2024, opening 443 new positions and adding to 269 existing holdings. Its largest new stake was TE Connectivity: 890,754 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 43% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $107M trimmed.
- Woodline Partners's largest Q4 2024 buy was TE Connectivity: 890,754 shares worth $127M.
- Woodline Partners added most to NVIDIA in Q4 2024, an estimated $217M increase.
- Woodline Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $107M.
- Woodline Partners fully exited ASML in Q4 2024, selling an estimated $125M.
- Woodline Partners's ten largest holdings make up 13% of its $14.8B portfolio in Q4 2024.
- Woodline Partners opened 443 new positions and closed 112 in Q4 2024.
- Woodline Partners's portfolio value rose 25% quarter-over-quarter to $14.8B.
Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.